Government of Singapore Investment Corporation was founded in 1981 and is based in Singapore with additional offices in South Korea, United Kingdom, United States, Japan, and China. Government of Singapore Investment Corporation Pte Ltd. (GIC) is a sovereign wealth fund of the Government of Singapore. The firm manages foreign exchange reserves of the Government of Singapore. It invests in the public and private equity, real estate, fixed income, and alternative markets including foreign exchange, commodity, and money markets across the globe. The firm invests through its subsidiaries GIC Asset Management Pte Ltd., GIC Real Estate Pte Ltd., and GIC Special Investments Pte Ltd.

The Bank of N.T. Butterfield & Son Limited was founded in 1858. The Bank of N.T. Butterfield & Son Limited provides community, commercial, and private banking services. It offers retail services, such as deposit services, consumer and mortgage lending, credit cards, and personal insurance products through telephone and Internet banking, automated teller machines, and debit cards to individuals and small to medium sized businesses; and corporate services, including commercial lending and mortgages, cash management, payroll services, remote banking, and letters of credit, as well as treasury services, which include money market and foreign exchange services. The company also provides investment management, advisory, and brokerage services; trust, estate, company management, and custody services; wealth management and fiduciary services; and private banking and treasury services, and administered bank services, as well as engages in the real estate business.

De Novo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons learned from a history of successful investing and building successful companies. They believed that their unique combination of skills and perspectives could help entrepreneurs to build companies which would have significant clinical impact and generate superior returns. Seven years later, this belief continues to hold true, demonstrated by De Novo investment success in selected medical device and biotechnology companies.With $650 million under management, De Novo has made more than 40 investments in medical devices and biotechnology across three funds. De Novo invest in all stages of enterprise development and growth – from early stage to late stage. De Novo unique background of leading companies as entrepreneurs and operating executives from start to exit enables us to advise entrepreneurs and management teams over the full life cycle of the company.Eight exits have occurred in DNV I -- four IPOs: Favrille (NASDAQ: FVRL), Fox Hollow Technologies (NASDAQ: EVVV), Renovis (NASDAQ: RNVS), and SenoRx (NASDAQ: SENO) and four acquisitions: CryoVascular Systems (Boston Scientific), TriVascular (Boston Scientific), LuMend (Johnson and Johnson) and Microvention (Terumo). DNV II has had one exit to date – Hansen Medical (NASDAQ: HNSN).

Abraxus Investments plc company seeks to invest in renewable energy, namely wind farms, primarily in Central and Eastern Europe where it sees strong development opportunities. Abraxus was formerly focused on commercial real estate in the same regions, but changed course in mid-2009 as property markets around the world turned sour. That year, the company set up a subsidiary in Romania to locate and develop investment opportunities. Abraxus has been in a bit of corporate limbo as it seeks to find its niche. In 2005, dissident shareholders attempted to oust Abraxus five board members, citing the company's poor performance. The coup was later overturned.

Greenlight Capital is a hedge fund firm that invests primarily in publicly traded North American corporate debt offerings and equities. Founded in 1996, the $6 billion Greenlight Capital also manages a fund of funds and a private equity fund through its affiliates, Greenlight Masters and Greenlight Private Equity Partners. It also operates Greenlight Capital Re, a property/casualty reinsurer. The company is led by activist investor David Einhorn, who has made a name for himself both in the boardroom and at the card table (as a finalist in the World Series of Poker).

Sarasin & Partners LLP is a London-based specialist investment management firm in which the local management are major shareholders. The firm employs over 170 people and manages approximately £9.8 billion. With a committed team of investment professionals in the foreground and a strong bank in the background, we aim to provide an unusual combination of successful investment performance and high service standards. Our objective is to be one of the most highly regarded investment managers for private clients and charities and to build the firm’s reputation as a distinctive, active manager in the institutional marketplace.Founded in 1841, Bank Sarasin today is one of Switzerland’s leading private banking institutions. Its success is based on trust, confidentiality, expertise and dedication, as well as on the sustainable development of asset management, its core business. The Sarasin group - headquartered in Basel, Switzerland - employs around 1,600 staff. In addition to its headquarters in Basel, the Bank has further offices in Geneva, Lugano and Zurich. Internationally, the Sarasin group has offices in Europe, Asia and the Middle East. Bank Sarasin is a public limited company whose shares are listed on the Swiss Stock Exchange, SWX. Its majority shareholder, Rabobank, enjoys the highest qualification of credit status (AAA-rated) from prominent international rating agencies. Measured by its core capital, Rabobank is one of the world's top twenty financial institutions.

Alliance Technology Ventures IV, L.P. specializes to make early, seed, and start up investments. It seeks to invest in communications, semiconductor, and life science companies with a focus on devices, systems, infrastructure, networks, and applications. It prefers to invest in broadband access and infrastructure with focus on wireless, cable, xDSL, and optical and in companies helping to advance Moore's Law. In life sciences, it seeks to invest in later-stage drug development programs, nanotech-based diagnostic and therapeutic innovations, and targeted protein-based therapeutics. The fund prefers to invest in the companies based in south-eastern U.S. It does not invest in publicly traded companies or companies located outside of the continental U.S. The fund typically invests between $1 million and $5 million in its portfolio companies.

Epoch Investment Partners, Inc. was founded in April 2004 and is based in New York, New York with an additional office in Sherman Oaks, California. Epoch Holding Corporation (Epoch) is a holding company whose primary line of business is investment advisory and investment management services. The operations of the Company are conducted through its wholly owned subsidiary, Epoch Investment Partners, Inc. (EIP). EIP provides investment advisory and investment management services for retirement plans, mutual funds, endowments, foundations and high net worth individuals. As of June 30, 2009, EIP offered 11 separate investment products to its clients, including U.S. All Cap Value, U.S. Value, U.S. Smid (small/mid) Cap Value, U.S. Small Cap Value, U.S. Choice, International Small Cap, Global Small Cap, Global Choice, Global Absolute Return, Global Equity Shareholder Yield and Balanced Portfolios.

Japan Securities Finance Co., Ltd., together with its subsidiaries, operates as a securities finance company in Japan. The company's services for securities companies and financial institutions comprise loans for margin transactions, including fund loans and stock loans; general stock lending that include lending stock certificates needed to settle stock trading; bond services comprising brokerage between borrowers and lenders in bond borrowing and lending market; loans for negotiable margin transactions comprising loan funds needed to settle negotiable margin transactions; bond financing, including loan funds needed in bond underwriting and trading; and general loans that consist of loan working funds to securities companies. It also offers secured loans on securities for individual and corporate investors comprising bond financing and general loans, which include direct loans to customer; and loans on securities in safekeeping account, within credit line set before. In addition, the company provides peripheral services, such as securities custody, which includes custody services for securities owned by institutional investors; and government bond debt servicing comprising repayment services for principal and interest on government bonds. Further, it engages in real estate ownership, leasing, trading, and brokerage, as well as offers insurance agency services.

Shenzhen Stock Exchange (SZSE)，established on 1st December 1990, is a self-regulated legal entity under the supervision of China Securities Regulatory Commission (CSRC). Its main functions include providing venue and facility for securities trading, formulating operational rules, arranging securities listing, organizing and supervising securities trading, offering membership supervision and oversight of listed companies, managing and publicizing market information and other capacities permitted by CSRC.SZSE is committed to its mission to develop China’s multi-tier capital market system. It gives full support to development in small and medium businesses and implementation of the national strategy of independent innovation. The SME Board was launched in May 2004. The ChiNext Market was inaugurated in October 2009. And the OTC market began its pilot program in Zhongguancun Science Park in January 2006. Thus SZSE has basically completed its framework for the multi-tier capital market system with coordinated development in the main board, SME board and ChiNext market. SZSE adheres to its basic principle of strict supervision and puts into practice the policy of “Regulation, Innovation, Cultivation and Service”. SZSE spares no effort in fostering an open, fair and just market environment.By 30 June 2010, SZSE was home to 1,012 listed companies, with 485 on the main board, 437 on the SME board and 90 on the ChiNext market. The total market capitalization was valued at 5.6 trillion yuan (US$828.7 billion). A total of 69 companies in Zhongguancun Science Park were quoted on the OTC market. In the first half of 2010, SZSE raised 154.3 billion yuan (US$22.7 billion) in IPO proceeds and recorded a total trading value of 9.73 trillion yuan (US$1.43 trillion). The multi-tier market, witnessing daily progress toward perfection, asserts its role in supporting the real economy and transformation of economic growth model.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.